{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:55:25Z","timestamp":1761155725395,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.revmed.2013.02.019","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T10:53:56Z","timestamp":1380106436000},"page":"196-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["R\u00e9ponse prolong\u00e9e apr\u00e8s traitement par tocilizumab d\u2019une polychondrite atrophiante"],"prefix":"10.1016","volume":"35","author":[{"given":"E.","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-B.","family":"Gaultier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Guichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Monard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cath\u00e9bras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2013.02.019_bib0005","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.autrev.2010.02.016","article-title":"Relapsing polychondritis: an autoimmune disease with many faces","volume":"9","author":"Lahmer","year":"2010","journal-title":"Autoimmune Rev"},{"key":"10.1016\/j.revmed.2013.02.019_bib0010","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.semarthrit.2011.08.006","article-title":"Biologics in relapsing polychondritis: a literature review","volume":"41","author":"Kemta Lekpa","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.019_bib0015","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/rheumatology\/ken468","article-title":"Sustained response to tocilizumab, anti-interleukin-6\u00a0receptor antibody, in two patients with refractory relapsing polychondritis","volume":"48","author":"Kawai","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2013.02.019_bib0020","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/rheumatology\/ker451","article-title":"Sustained response to tocilizumab, anti-IL-6\u00a0antibody, following anti-TNF-\u03b1 failure in a patient with relapsing polychondritis complicated by aortitis","volume":"51","author":"Narshi","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2013.02.019_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.berh.2012.01.001","article-title":"Tocilizumab\u00a0\u2013\u00a0a novel therapy for non-organ-specific autoimmune diseases","volume":"26","author":"Kaly","year":"2012","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.revmed.2013.02.019_bib0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.revmed.2012.01.012","article-title":"Actualit\u00e9s sur l\u2019inhibition de l\u2019interleukine-1","volume":"33","author":"de Boysson","year":"2012","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2013.02.019_bib0035","article-title":"Successful use of tocilizumab in a Caucasian patient with relapsing polychondritis complicated by Sweet's syndrome","author":"Chana","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2013.02.019_bib0040","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/rheumatology\/kem229","article-title":"Prolonged response to anti-tumor necrosis factor treatment with adalimumab (Humira) in relapsing polychondritis complicated by aortitis","volume":"46","author":"Seymour","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2013.02.019_bib0045","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1002\/art.20613","article-title":"Serum cytokine profiles in relapsing polychondritis suggest monocyte\/macrophage activation","volume":"11","author":"Stabler","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2013.02.019_bib0050","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/rheumatology\/keq343","article-title":"Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials","volume":"50","author":"Campbell","year":"2011","journal-title":"Rheumatology"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313000659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866313000659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:32:37Z","timestamp":1759336357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866313000659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0248866313000659"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2013.02.019","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9ponse prolong\u00e9e apr\u00e8s traitement par tocilizumab d\u2019une polychondrite atrophiante","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2013.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}